Published in Adv Enzyme Regul on July 20, 2006
Neuronal IP3 3-kinase is an F-actin-bundling protein: role in dendritic targeting and regulation of spine morphology. Mol Biol Cell (2009) 1.48
Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate. Nat Rev Immunol (2010) 1.17
Lipid signaling in T-cell development and function. Cold Spring Harb Perspect Biol (2010) 1.08
Reliable encoding of stimulus intensities within random sequences of intracellular Ca2+ spikes. Sci Signal (2014) 0.99
Computational quest for understanding the role of astrocyte signaling in synaptic transmission and plasticity. Front Comput Neurosci (2012) 0.94
Localization, regulation and function of type II phosphatidylinositol 5-phosphate 4-kinases. Adv Enzyme Regul (2009) 0.88
Phosphoinositide and inositol phosphate analysis in lymphocyte activation. Curr Protoc Immunol (2009) 0.85
Dvl3 translocates IPMK to the cell membrane in response to Wnt. Cell Signal (2012) 0.80
IP3 3-kinase opposes NGF driven neurite outgrowth. PLoS One (2012) 0.79
Defining signal transduction by inositol phosphates. Subcell Biochem (2012) 0.79
Modulation of Epidermal Growth Factor Stimulated ERK Phosphorylation and Cell Motility by Inositol Trisphosphate Kinase. J Pharm Sci Pharmacol (2014) 0.76
ITPKA expression is a novel prognostic factor in hepatocellular carcinoma. Diagn Pathol (2015) 0.75
Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature (1984) 25.71
Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature (1983) 10.90
The inositol trisphosphate phosphomonoesterase of the human erythrocyte membrane. Biochem J (1982) 6.82
Rapid formation of inositol 1,3,4,5-tetrakisphosphate following muscarinic receptor stimulation of rat cerebral cortical slices. Biochem J (1985) 5.79
The inositol tris/tetrakisphosphate pathway--demonstration of Ins(1,4,5)P3 3-kinase activity in animal tissues. Nature (1986) 5.41
Rapid actin-based plasticity in dendritic spines. Neuron (1998) 4.70
Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol (2001) 3.69
A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. Science (2000) 3.63
Phosphorylation of proteins by inositol pyrophosphates. Science (2004) 3.27
Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci (1998) 2.55
Specificity of inositol phosphate-stimulated Ca2+ mobilization from Swiss-mouse 3T3 cells. Biochem J (1986) 2.30
Identification of a specific Ins(1,3,4,5)P4-binding protein as a member of the GAP1 family. Nature (1995) 2.20
Regulation of spine calcium dynamics by rapid spine motility. J Neurosci (2000) 2.14
Inositol trisphosphate mediates a RAS-independent response to LET-23 receptor tyrosine kinase activation in C. elegans. Cell (1998) 2.03
Phospholipase C-gamma is required for agonist-induced Ca2+ entry. Cell (2002) 1.92
Inositol diphosphate signaling regulates telomere length. J Biol Chem (2004) 1.85
Inositol 1,3,4,5-tetrakisphosphate is essential for sustained activation of the Ca2+-dependent K+ current in single internally perfused mouse lacrimal acinar cells. J Membr Biol (1989) 1.52
Assessing the omnipotence of inositol hexakisphosphate. Cell Signal (2001) 1.51
An essential role for an inositol polyphosphate multikinase, Ipk2, in mouse embryogenesis and second messenger production. Proc Natl Acad Sci U S A (2005) 1.48
The metabolism of tris- and tetraphosphates of inositol by 5-phosphomonoesterase and 3-kinase enzymes. J Biol Chem (1987) 1.41
Structure of a human inositol 1,4,5-trisphosphate 3-kinase: substrate binding reveals why it is not a phosphoinositide 3-kinase. Mol Cell (2004) 1.39
Agonist-induced regulation of mitochondrial and endoplasmic reticulum motility. Biochem J (2005) 1.37
Disruption of the mouse inositol 1,3,4,5,6-pentakisphosphate 2-kinase gene, associated lethality, and tissue distribution of 2-kinase expression. Proc Natl Acad Sci U S A (2005) 1.37
Inositol polyphosphate kinase activity of Arg82/ArgRIII is not required for the regulation of the arginine metabolism in yeast. FEBS Lett (2000) 1.36
Inositol 1,4,5-trisphosphate 3-kinase A associates with F-actin and dendritic spines via its N terminus. J Biol Chem (2001) 1.35
Selective localization of high concentrations of F-actin in subpopulations of dendritic spines in rat central nervous system: a three-dimensional electron microscopic study. J Comp Neurol (2001) 1.33
Inositol polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory activity. Proc Natl Acad Sci U S A (2005) 1.24
Crystal structure of the catalytic core of inositol 1,4,5-trisphosphate 3-kinase. Mol Cell (2004) 1.22
Inositol (1,4,5) trisphosphate 3 kinase B controls positive selection of T cells and modulates Erk activity. Proc Natl Acad Sci U S A (2004) 1.20
Caenorhabditis elegans inositol 5-phosphatase homolog negatively regulates inositol 1,4,5-triphosphate signaling in ovulation. Mol Biol Cell (2002) 1.20
Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development. Nat Immunol (2003) 1.16
How do inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate regulate intracellular Ca2+? Biochem Soc Trans (1989) 1.10
Enhanced hippocampal CA1 LTP but normal spatial learning in inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice. Learn Mem (1999) 1.09
Agonist-induced regulation of inositol tetrakisphosphate isomers and inositol pentakisphosphate in adrenal glomerulosa cells. J Biol Chem (1989) 1.06
Inositide evolution - towards turtle domination? J Physiol (2005) 1.04
Ins(1,4,5)P3 metabolism and the family of IP3-3Kinases. Cell Signal (2004) 1.04
Isoprenylated human brain type I inositol 1,4,5-trisphosphate 5-phosphatase controls Ca2+ oscillations induced by ATP in Chinese hamster ovary cells. J Biol Chem (1997) 1.01
Membrane association, localization and topology of rat inositol 1,4,5-trisphosphate 3-kinase B: implications for membrane traffic and Ca2+ homoeostasis. Biochem J (1997) 0.96
Rat inositol 1,4,5-trisphosphate 3-kinase C is enzymatically specialized for basal cellular inositol trisphosphate phosphorylation and shuttles actively between nucleus and cytoplasm. J Biol Chem (2003) 0.94
Inositol 1,4,5-trisphosphate 3-kinase distribution in the rat brain. High levels in the hippocampal CA1 pyramidal and cerebellar Purkinje cells suggest its involvement in some memory processes. Brain Res (1991) 0.93
Calcium-triggered exit of F-actin and IP(3) 3-kinase A from dendritic spines is rapid and reversible. Eur J Neurosci (2006) 0.93
The three isoenzymes of human inositol-1,4,5-trisphosphate 3-kinase show specific intracellular localization but comparable Ca2+ responses on transfection in COS-7 cells. Biochem J (2003) 0.92
D-myo-inositol 1,4,5-trisphosphate 3-kinase A is activated by receptor activation through a calcium:calmodulin-dependent protein kinase II phosphorylation mechanism. EMBO J (1997) 0.89
Calcium-calmodulin-dependent protein kinase II and protein kinase C-mediated phosphorylation and activation of D-myo-inositol 1,4, 5-trisphosphate 3-kinase B in astrocytes. J Biol Chem (1999) 0.89
Molecular study and regulation of D-myo-inositol 1,4,5-trisphosphate 3-kinase. Cell Signal (1995) 0.89
Identification of the actin-binding domain of Ins(1,4,5)P3 3-kinase isoform B (IP3K-B). Biochem J (2004) 0.88
Inositol 1,3,4,5-tetrakisphosphate and Ca2+ homoeostasis: the role of GAP1IP4BP. Biochem Soc Trans (1997) 0.88
Underexpression of the 43 kDa inositol polyphosphate 5-phosphatase is associated with spontaneous calcium oscillations and enhanced calcium responses following endothelin-1 stimulation. J Cell Sci (1999) 0.86
Calpain cleavage of the B isoform of Ins(1,4,5)P3 3-kinase separates the catalytic domain from the membrane anchoring domain. Biochem J (2003) 0.86
Possible roles of inositol 1,4,5-trisphosphate 3-kinase B in calcium homeostasis. FEBS Lett (1997) 0.82
The structural integrity of the endoplasmic reticulum, and its possible regulation by inositol 1,3,4,5-tetrakisphosphate. Cell Calcium (2005) 0.81
Tissue-specific expression and endogenous subcellular distribution of the inositol 1,3,4,5-tetrakisphosphate-binding proteins GAP1(IP4BP) and GAP1(m). Biochem Biophys Res Commun (1999) 0.81
Regulation of the localization and activity of inositol 1,4,5-trisphosphate 3-kinase B in intact cells by proteolysis. Biochem J (2005) 0.81
A novel receptor-mediated regulation mechanism of type I inositol polyphosphate 5-phosphatase by calcium/calmodulin-dependent protein kinase II phosphorylation. J Biol Chem (2001) 0.79
Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res (2005) 5.04
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. J Clin Oncol (2002) 2.51
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer. J Clin Oncol (2009) 2.13
Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J Biol Chem (2008) 2.07
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol (2008) 1.97
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer. J Clin Oncol (2010) 1.88
Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer. Clin Cancer Res (2005) 1.84
12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci Rep (2012) 1.81
Suicide in patients with pancreatic cancer. Cancer (2010) 1.62
Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J Cell Sci (2007) 1.62
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia. Clin Cancer Res (2006) 1.61
Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer. J Clin Oncol (2013) 1.55
Neuronal IP3 3-kinase is an F-actin-bundling protein: role in dendritic targeting and regulation of spine morphology. Mol Biol Cell (2009) 1.48
Structure of a human inositol 1,4,5-trisphosphate 3-kinase: substrate binding reveals why it is not a phosphoinositide 3-kinase. Mol Cell (2004) 1.39
Agonist-induced regulation of mitochondrial and endoplasmic reticulum motility. Biochem J (2005) 1.37
Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore. J Biol Chem (2001) 1.29
ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood (2006) 1.27
Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Am J Pathol (2009) 1.20
Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr (2002) 1.19
Determinants of metabotropic glutamate receptor-5-mediated Ca2+ and inositol 1,4,5-trisphosphate oscillation frequency. Receptor density versus agonist concentration. J Biol Chem (2002) 1.18
Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells. Mol Biol Cell (2003) 1.16
Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer. Cancer (2008) 1.15
The false discovery rate: a key concept in large-scale genetic studies. Cancer Control (2010) 1.14
Effects of lipid kinase expression and cellular stimuli on phosphatidylinositol 5-phosphate levels in mammalian cell lines. FEBS Lett (2005) 1.13
Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer. Lung Cancer (2005) 1.12
Optimism bias leads to inconclusive results-an empirical study. J Clin Epidemiol (2010) 1.12
Continuous toxicity monitoring in phase II trials in oncology. Biometrics (2005) 1.12
ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling. Mol Cell Biol (2011) 1.11
A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer (2012) 1.05
ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis. Am J Pathol (2010) 1.04
Do mammals make all their own inositol hexakisphosphate? Biochem J (2008) 1.03
Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia (2010) 1.00
Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer (2005) 1.00
Type IIalpha phosphatidylinositol phosphate kinase associates with the plasma membrane via interaction with type I isoforms. Biochem J (2002) 0.98
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older. Cancer (2008) 0.98
Nuclear inositide signalling -- expansion, structures and clarification. Biochim Biophys Acta (2006) 0.98
Genomic tagging reveals a random association of endogenous PtdIns5P 4-kinases IIalpha and IIbeta and a partial nuclear localization of the IIalpha isoform. Biochem J (2010) 0.97
Agonist-evoked inositol trisphosphate receptor (IP3R) clustering is not dependent on changes in the structure of the endoplasmic reticulum. Biochem J (2006) 0.96
Relationship of gliomas to the ventricular walls. J Clin Neurosci (2008) 0.94
Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer. J Thorac Oncol (2010) 0.93
Decision-making when data and inferences are not conclusive: risk-benefit and acceptable regret approach. Semin Hematol (2008) 0.91
Improved survival modeling in cancer research using a reduced piecewise exponential approach. Stat Med (2013) 0.91
Racial differences in prostate androgen levels in men with clinically localized prostate cancer. J Urol (2004) 0.90
Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells. Cancer Biol Ther (2009) 0.89
Complex cell cycle abnormalities caused by human T-lymphotropic virus type 1 Tax. J Virol (2011) 0.88
Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinoma. J Immunother (2013) 0.87
Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel. Cancer (2002) 0.87
A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors. Clin Cancer Res (2014) 0.86
Comparing Two Exponential Distributions Using the Exact Likelihood Ratio Test. Stat Biopharm Res (2012) 0.84
Regulation of inositol 1,4,5-trisphosphate 3-kinases by calcium and localization in cells. J Biol Chem (2007) 0.84
Comparison of three methods to increase knowledge about breast cancer and breast cancer screening in screening mammography patients. Acad Radiol (2007) 0.84
Factors predicting successful needle-localized breast biopsy. Acad Radiol (2003) 0.83
Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing. J Clin Pathol (2014) 0.83
Muscarinic acetylcholine receptor activation enhances hippocampal neuron excitability and potentiates synaptically evoked Ca(2+) signals via phosphatidylinositol 4,5-bisphosphate depletion. Mol Cell Neurosci (2005) 0.82
Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status. Lung Cancer (2005) 0.81
Regulation of the localization and activity of inositol 1,4,5-trisphosphate 3-kinase B in intact cells by proteolysis. Biochem J (2005) 0.81
Nerve growth factor-induced stimulation of p38 mitogen-activated protein kinase in PC12 cells is partially mediated via G(i/o) proteins. Cell Signal (2008) 0.80
Analysis of group randomized trials with multiple binary endpoints and small number of groups. PLoS One (2009) 0.80
Copper directs ATP7B to the apical domain of hepatic cells via basolateral endosomes. Traffic (2014) 0.79
Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers. Cancer (2012) 0.78
Expression of CXCR4, E-cadherin, Bcl-2, and survivin in Merkel cell carcinoma: an immunohistochemical study using a tissue microarray. Am J Dermatopathol (2012) 0.77
IP3-dependent intracellular Ca2+ release is required for cAMP-induced c-fos expression in hippocampal neurons. Biochem Biophys Res Commun (2012) 0.76
Recall and detection rates in screening mammography. Cancer (2004) 0.76
Identifying risk factors using a skin cancer screening program. Cancer Control (2013) 0.75
A predictive risk probability approach for microarray data with survival as an endpoint. J Biopharm Stat (2008) 0.75
Influence of serum and tissue micronutrient levels on the regression of untreated cervical intraepithelial neoplasia 2 and 3. J Low Genit Tract Dis (2002) 0.75
Effect of Age on Clinical Outcomes in Phase 1 Trial Participants. Cancer Control (2015) 0.75
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021. Emerg Infect Dis (2022) 0.75
A femtomole-sensitivity mass assay for inositol hexakisphosphate. Methods Mol Biol (2010) 0.75